The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

TUESDAY, Sept. 3, 2024 -- Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior...

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF)...

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF)...

WEDNESDAY, Sept. 11, 2024 -- Breast arterial calcifications (BAC) identified on mammography are associated with the development of both...

FRIDAY, Sept. 13, 2024 -- For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication...

Up to a million people in the UK live with heart failure, a condition that reduces quality of life and increases the risk of hospital admission.

The anti-obesity medication semaglutide may help to prevent medlinkheart attacks/medlink, medlinkstrokes/medlink, and other major adverse...